Key Points
- 1. The total Ebola death toll in the Democratic Republic of the Congo and Uganda rose to 1001.
- 2. In the Democratic Republic of the Congo, 999 people lost their lives, while 2473 confirmed cases were found.
- 3. The first clinical trials have begun for the ChAdOx1 Ebola vaccine developed under the leadership of Oxford University.
By the Numbers
According to the latest data announced by the World Health Organization, the number of deaths from the Ebola outbreak in the Democratic Republic of the Congo and Uganda has reached 1001. While 999 deaths and 2473 confirmed cases were recorded in the Democratic Republic of the Congo, two people lost their lives and 20 cases were detected in neighboring Uganda.
Last week, Ugandan authorities confirmed that there are no active Ebola cases remaining in the country. In contrast, WHO indicates that the fight continues in the Democratic Republic of the Congo, which is the epicenter of the outbreak. In the last 50 years, the Ebola virus has caused the deaths of more than 15 thousand people on the African continent.
WHO launched clinical trials for two different drugs against the latest rare strain of the virus and granted emergency use approval for the first molecular diagnostic test. In addition, initial trials have been launched to evaluate the safety of an Ebola vaccine called ChAdOx1, developed under the leadership of Oxford University in the United Kingdom.
React to this story
Ask about this story
Answers are AI-generated from this story only.
Frequently Asked Questions
- 1. Q: What was the total death toll in the Ebola outbreak?
- A: According to World Health Organization data, the total death toll in the Ebola outbreak in the Democratic Republic of the Congo and Uganda has reached 1001.
- 2. Q: What stage is the Ebola situation in Uganda at?
- A: 20 cases and 2 deaths have been recorded in Uganda, and authorities announced that there are currently no active Ebola cases in the country.
- 3. Q: Is there a new vaccine study against the Ebola virus?
- A: Yes, initial clinical trials have been launched to test the safety of the ChAdOx1 vaccine, developed under the leadership of Oxford University in the United Kingdom.
This is an AI-generated summary. The full story lives at the source.
Read the full story at the sourceannahar.comHow we produce our content →This story across sources · 2 · 2 countries
- Akşam Postası·
- Panay News·